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The most dramatic physiological change associ-
ated with birth is the onset of respiration. Mam-
mals must breathe within minutes of birth to 
deliver oxygen to the brain and other organs, yet 
the lungs develop in a fluid environment and do 
not function until the time of birth. Successful 
neonatal respiration requires a complex prenatal 
lung maturation program that prepares the lung 
for air inflation and gas exchange at birth. A key 
aspect of this preparation is mechanical, i.e., in-
creasing the compliance of the lung so that it 
can be successfully inflated at the time of birth 
(Guyton and Hall, 2000). A known regulator of 
pulmonary compliance is surfactant, a lipopro-
tein mixture produced in the late gestation lung 
that increases lung compliance by reducing al-
veolar surface tension (Avery and Mead, 1959; 
Adams et al., 1965; Morgan, 1971). The impor-
tance of prenatal lung maturation in neonatal 
respiration is revealed by the high incidence of 
respiratory failure, termed respiratory distress syn-
drome (RDS), among infants born before 29 wk 
of gestation (Hintz et al., 2005). Surfactant ad-
ministration improves pulmonary compliance 
and RDS mortality (Couser et al., 1990), but pre-
mature infants still require supportive care such 
as oxygen and mechanical ventilation that are as-
sociated with long-term complications (Hintz 
et al., 2005; Suresh and Soll, 2005). The identifi-
cation of additional mechanical aspects of lung 
maturation that may contribute to the patho-
genesis of RDS is necessary to more effectively 
treat this common disease.
CORRESPONDENCE  
Mark L. Kahn:  
markkahn@mail.med.upenn.edu
Abbreviation used: RDS, respi-
ratory distress syndrome.
S.H. Guttentag’s present address is Dept. of Pediatrics, Van-
derbilt University, Nashville, TN 37232
Lymphatic function is required prenatally  
for lung inflation at birth
Zoltán Jakus,1,2 Jason P. Gleghorn,4 David R. Enis,3 Aslihan Sen,1,2 
Stephanie Chia,1,2 Xi Liu,1,2,5 David R. Rawnsley,1,2 Yiqing Yang,1,2  
Paul R. Hess,1,2 Zhiying Zou,1,2 Jisheng Yang,1,2 Susan H. Guttentag,6 
Celeste M. Nelson,4 and Mark L. Kahn1,2
1Department of Medicine, 2Cardiovascular Institute, and 3Department of Dermatology, University of Pennsylvania, 
Philadelphia, PA 19104
4Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08544
5Fourth Military Medical University, Xi’an 710032, China
6Department of Neonatology, Children’s Hospital of Philadelphia, Philadelphia, PA 19104
Mammals must inflate their lungs and breathe within minutes of birth to survive. A key 
regulator of neonatal lung inflation is pulmonary surfactant, a lipoprotein complex which 
increases lung compliance by reducing alveolar surface tension (Morgan, 97). Whether 
other developmental processes also alter lung mechanics in preparation for birth is un-
known. We identify prenatal lymphatic function as an unexpected requirement for neonatal 
lung inflation and respiration. Mice lacking lymphatic vessels, due either to loss of the 
lymphangiogenic factor CCBE or VEGFR3 function, appear cyanotic and die shortly after 
birth due to failure of lung inflation. Failure of lung inflation is not due to reduced surfac-
tant levels or altered development of the lung but is associated with an elevated wet/dry 
ratio consistent with edema. Embryonic studies reveal active lymphatic function in the late 
gestation lung, and significantly reduced total lung compliance in late gestation embryos 
that lack lymphatics. These findings reveal that lymphatic vascular function plays a previ-
ously unrecognized mechanical role in the developing lung that prepares it for inflation at 
birth. They explain respiratory failure in infants with congenital pulmonary lymphangiecta-
sia, and suggest that inadequate late gestation lymphatic function may also contribute to 
respiratory failure in premature infants.
© 2014 Jakus et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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were frequently indistinguishable from control littermates 
(Fig. 1 B). It has been thought that lymphatic-deficient animals 
die due to loss of intravascular fluid which leads to cardiovascu-
lar collapse and death, but histological analysis and trans-uterine 
ultrasound revealed normal heart structure and function in 
E18.5–19.5 CCBE1-deficient embryos (Fig. 1, C and D). These 
findings reveal that Ccbe1/ embryos do not die prenatally due 
to cardiovascular causes.
CCBE-deficient and Vegfr3kd/kd neonates  
are cyanotic and die of respiratory failure
To determine if CCBE1-deficient animals die around the 
time of birth, heterozygous matings were performed and off-
spring retrieved immediately after natural birth. All wild-
type and Ccbe1+/ pups achieved a pink color consistent with 
normal tissue oxygenation within 5–20 min and were viable 
for >60 min after delivery (Fig. 2 A). In contrast, almost all 
Ccbe1/ pups appeared severely cyanotic and died within 
3 h (Fig. 2 A). An identical phenotype was observed when 
Ccbe1/ pups were retrieved by Caesarean (C) section at 
E19.5 (Fig. 2 B, n = 12/13; P < 0.0001 compared with con-
trol), whereas all control littermates achieved a pink color and 
The lymphatic vascular network is comprised of an open 
capillary system that drains fluid and proteins that have leaked 
from the high pressure blood vascular network into the inter-
stitium. The prevention of tissue edema is considered a univer-
sal role of lymphatics and one that operates in a similar fashion 
and for a similar purpose in all tissues except the central ner-
vous system, where a tight blood–brain barrier prevents fluid 
and protein leak. In addition to its global role in preventing tis-
sue edema, lymphatic vessels are known to play specialized roles 
in coordinating adaptive immune responses in secondary lym-
phoid organs and in the transport of dietary lipids from the 
intestine (Tammela and Alitalo, 2010; Wang and Oliver, 2010). 
Whether lymphatic vessels play other organ-specific roles is 
not yet known.
In the present study, we examine the cause of death of mice 
that lack all lymphatic vessels due to loss of the secreted lym-
phangiogenic factor CCBE1 or signaling by the lymphatic en-
dothelial receptor VEGFR3. We find that loss of lymphatic 
function has no major cardiovascular effects before birth, but 
that lymphatic-deficient animals die immediately after birth 
due to respiratory failure. Neonatal respiratory failure in lym-
phatic-deficient animals is not due to impaired gas exchange, 
compressive pleural effusions, or an unexpected role for lym-
phatic vessels in the molecular or cellular development of the 
lung. Instead, lymphatic function is required before birth in the 
late gestation lung to increase lung compliance and alter lung 
mechanics in preparation for inflation at birth. These studies 
reveal new insights into the function of the lymphatic system 
during lung development that explain respiratory failure in in-
fants with congenital pulmonary lymphangiectasia, and iden-
tify an organ-specific, mechanical role for lymphatic vessels that 
may contribute to RDS in premature infants.
RESULTS
CCBE-deficient animals lacking  
lymphatic vessels do not die in utero
Mutant mice that lack all lymphatics (e.g., those lacking the 
lymphatic endothelial transcription factor PROX1 [Wigle and 
Oliver, 1999], the lymphangiogenic factors VEGFC [Karkkainen 
et al., 2004] or CCBE1 [Zou et al., 2013], or the lymphatic en-
dothelial growth factor receptor VEGFR3 [Karkkainen et al., 
2001; Zhang et al., 2010]) do not survive past birth, but when 
and why animals lacking lymphatic vessels die has not been es-
tablished. Analysis of midgestation Ccbe1/ embryos revealed 
normal blood vascular development, a complete lack of lym-
phatic vessels, and one third of deficient animals exhibited 
midgestation embryonic anemia on a mixed 129SV;C57BL/6 
background (Zou et al., 2013). No live Ccbe1/ neonates were 
recovered at postnatal day 0.5 (P0.5), but two thirds of Ccbe1/ 
embryos were not pale and had normal hematocrits at embry-
onic day 17.5–18.5 (E17.5–18.5; Fig. 1 A). Like embryos lack-
ing VEGFC or VEGFR3 signaling (Karkkainen et al., 2001, 
2004; Zhang et al., 2010), E14.5 Ccbe1/ embryos exhibited 
marked midgestation cutaneous edema (Zou et al., 2013), but 
this improved in late gestation and by E18.5 Ccbe1/ embryos 
Figure . Non-anemic Ccbe/ embryos survive to late gestation 
with normal cardiovascular function. (A) E17–18 Ccbe1/ embryos 
that did not appear pale were selected for studies of lung function. The 
hematocrits of non-pale Ccbe1/ embryos were not reduced compared 
with littermate controls. Quantitative data are represented as mean and 
SEM from 8 control and 5 Ccbe1/ embryos from 3 independent litters 
(P = 0.40). (B) Gross appearance of Ccbe1/ and control littermate em-
bryos at E18.5. Representative images are shown from 81 control and  
20 Ccbe1/ E18.5 embryos examined from 15 litters. Bars, 5 mm. (C) Car-
diac size and structure of Ccbe1/ and control littermate embryos are 
shown at E18.5 by H-E staining. Images are representative of 5 control 
and 5 Ccbe1/ embryos examined from 3 independent litters. Bars,  
1,000 µm. (D) Cardiac ejection fraction and fractional shortening of E18.5 
Ccbe1/ and littermate control embryos determined by transuterine 
ultrasound. Quantitative data for ejection fraction and fractional short-
ening are represented as mean and SEM from 7 control and 4 Ccbe1/ 
embryos examined from 3 independent litters (P = 0.2 and P = 0.14 for 
ejection fraction and fractional shortening, respectively).
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autonomously for lymphatic endothelial and vessel growth 
(Mäkinen et al., 2001), and its expression is entirely re-
stricted to lymphatic endothelial cells in the developing lung 
(Kaipainen et al., 1995; Janér et al., 2006; Kulkarni et al., 
2011). The Vegfr3kd allele encodes a dominant-negative pro-
tein that confers postnatal lethality in heterozygous animals 
that is ameliorated on specific permissive genetic backgrounds 
(i.e., C3H or NMRI; Karkkainen et al., 2001; Zhang et al., 
2010). Observation of natural births and C-section at E19.5 
revealed cyanosis and respiratory failure in Vegfr3kd/kd but 
not wild-type or Vegfr3kd/+ neonates which was identical 
to that observed in Ccbe1/ neonates (n = 8/13 in the 
C-section group, discussed further below; Fig. 2, D and E; 
and Video 2).
survived (n = 47). Ccbe1/ pups had normal diaphragms and 
exhibited gasping and costal retractions, indicative of normal 
neuromuscular function and respiratory drive (Fig. 2 C and 
Video 1). Thus, CCBE1-deficient mice lacking lymphatics 
exhibit respiratory failure immediately after birth, and die 
soon thereafter.
Respiratory failure in CCBE1-deficient neonates could 
reflect a requirement for lymphatic function for neonatal res-
piration, or an unexpected role for CCBE1 in lung develop-
ment. Because the mechanism of action of secreted CCBE1 
is unknown, to further define the role of lymphatic function 
in neonatal respiration we next examined Vegfr3kd/kd mice that 
lack lymphatic vessels due to a point mutation in the ki-
nase domain of VEGFR3. VEGFR3 function is required cell 
Figure 2. Animals lacking lymphatic ves-
sels exhibit cyanosis and respiratory fail-
ure immediately after birth. (A) Cyanotic 
state of Ccbe1/ neonates after natural 
birth. Representative littermates are shown. 
Bar, 5 mm. (B) Cyanotic state of Ccbe1/ 
neonates after C-section at E19.5. Bar, 5 mm. 
These animals are also shown in Video 1. Rep-
resentative neonates are shown from 47 lit-
termate control and 13 Ccbe1/ animals 
examined from 8 independent litters. (C) H-E 
staining of the diaphragms of Ccbe1/ and 
control littermate embryos. Frontal sections of 
the intact chest of the indicated E18.5 em-
bryos were stained with H-E. Bars, 500 µm.  
D indicates diaphragm. The images are repre-
sentative of 3 control and 3 Ccbe1/ em-
bryos examined at E18.5 from 3 independent 
litters. (D) Cyanotic state of Vegfr3kd/kd neo-
nates after natural birth compared with con-
trol littermates. Bar, 5 mm. (E) Cyanotic state 
of Vegfr3kd/kd neonates after C-section at 
E19.5 compared with control littermates.  
Bar, 5 mm. These animals are also shown in 
Video 2. Representative images are shown 
from 35 littermate control and 13 Vegfr3kd/kd 
neonates examined from 6 independent lit-
ters. Images in A, B, D, and E were obtained  
30 min after birth or C-section. (F and G) H-E 
staining of lung sections to show alveolar 
septae and alveolar air spaces in Ccbe1/ 
and cyanotic Vegfr3kd/kd neonates compared 
with control littermates 60 min after birth. 
Bars, 50 µm. Representative images are shown 
from 5–6 control and 4–5 lymphatic deficient 
neonates examined from 3–4 independent 
litters in each group. (H and I) Measurement 
of alveolar septal thickness and area in Ccbe1/, cyanotic Vegfr3kd/kd neonates, and littermate controls. Quantitative data are represented as mean and 
SEM for septal thickness and alveolar area. n = 5–6 control and 4–5 lymphatic-deficient neonates per genotype from 3–4 litters in each group (Ccbe1/: 
P < 0.001 and P < 0.01 for septal thickness and alveolar area, respectively; Vegfr3kd/kd: P < 0.0001 and P < 0.001 for septal thickness and alveolar area, 
respectively). (J) Trichrome staining of alveolar septae and alveolar area in Ccbe1/ and cyanotic Vegfr3kd/kd neonatal lungs compared with control littermates  
60 min after birth. Bars, 50 µm. Representative images are shown from 3 control and 3 lymphatic deficient neonates from 3 independent litters examined  
in each group. (K) Ccbe1/ and control neonate lung wet/dry (W/D) ratios of lung weight. Quantitative data are represented as mean and SEM from  
10 control and 3 Ccbe1/ neonates from 2 independent litters (P = 0.02). Asterisks indicate P < 0.05 compared with control.
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Figure 3. Loss of CCBE or VEGFR3 signaling does not affect the development of lung cell types other than lymphatic vessels. (A–M) E18.5 
Ccbe1/, Vegfr3kd/kd, and control littermate embryonic lungs were stained for markers of lung endothelial cells (PECAM), lung Clara cells (CC-10), alveolar 
Type II cells (pro-surfactant protein C [SPC]), Type I cells (PODOPLANIN [PDPN] and CAVEOLIN1 [CAV1]), lymphatic endothelial cells (PROX1 and LYVE1), 
mesenchyme (PDGFR), vascular smooth muscle cells and pericytes (PDGFR, SM22 and NG2), blood vessels (vimentin and desmin), and mesothelium 
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Loss of lymphatic function results in pulmonary edema  
but does not alter molecular or cellular lung development
H-E staining of lung tissue sections from both Ccbe1/ and 
cyanotic Vegfr3kd/kd neonates revealed normal lung structure, 
but alveolar interstitial thickness was significantly increased 
and alveolar area significantly reduced compared with control 
littermates 60 min after birth (Fig. 2, F–I). These changes were 
also easily detected using trichrome staining of control and 
mutant neonatal lungs (Fig. 2 J). Measurement of the lung 
wet/dry (W/D) ratio 60 min after C-section revealed a signifi-
cantly higher fluid content in Ccbe1/ lungs (Fig. 2 K), con-
sistent with pulmonary edema. In contrast, immunostaining 
revealed a normal PECAM+ blood vascular endothelial net-
work, normal numbers of CC10+ Clara cells and pro-SPC+ 
Type II pneumocytes, and a total lack of PROX1+;LYVE1+ 
lymphatic vessels in neonatal Ccbe1/ and Vegfr3kd/kd lungs 
(Fig. 3, A–C). Staining for the Type I cells markers podoplanin 
and caveolin1 was similar in control, Ccbe1/, and Vegfr3kd/kd 
lungs (Fig. 3, D and E). Finally, extensive immunostaining and 
qPCR analysis of lung developmental markers revealed nor-
mal levels of mesenchymal markers (PDGFR), vascular smooth 
muscle cells and pericytes (PDGFR, SM22, and NG2), blood 
vessel markers (vimentin [Schnitzer et al., 1981] and desmin 
[Morikawa et al., 2002]), and mesothelial cells (Fig. 3, F–N). 
These studies reveal that neonatal respiratory failure is due to 
loss of lymphatic fluid drainage rather than loss of the specific 
molecular action of CCBE1 or VEGFR3, and that loss of lym-
phatic function does not disturb molecular or cellular matura-
tion of the lung.
Mice lacking lymphatic function are unable  
to inflate their lungs after birth
Why do mice lacking lymphatic vessels exhibit cyanosis and 
respiratory failure after birth? The preservation of lung devel-
opment and cardiovascular function supported a defect in 
pulmonary physiology, and the thickened alveolar walls and 
elevated W/D ratio suggested that cyanosis might result from 
reduced oxygen diffusion. To determine if cyanosis was due to 
reduced oxygen diffusion, Ccbe1/ neonates were exposed to 
100% oxygen for 30 min. 100% oxygen failed to improve cya-
nosis (Fig. 4 A, n = 3), indicating the passage of blood through 
the lung without gas exchange. The physiological basis for 
this shunt was revealed by comparison of rare non-cyanotic 
Ccbe1/ neonates (1/13) and more frequent non-cyanotic 
Vegfr3kd/kd neonates (5/13) with their cyanotic littermates. 
Lungs from all non-cyanotic Ccbe1/ and Vegfr3kd/kd neonates 
floated when placed in saline, whereas those from all cyanotic 
Vegfr3kd/kd or Ccbe1/ neonates sank (Figs. 4, B and C; n = 9, 
P < 0.003), indicating that cyanosis resulted from a failure 
of lung inflation. Histological examination of non-cyanotic 
Vegfr3kd/kd neonates revealed small pockets of normal-appearing 
lung with thin interstitia and large alveoli, suggesting that par-
tial inflation of the lung was sufficient to oxygenate the neo-
nate and allow the excised lung to float (Fig. 4 D). These findings 
identify failure of lung inflation as the cause of respiratory fail-
ure in mice without lymphatic vessels. The higher frequency 
of partial lung inflation among Vegfr3kd/kd neonates compared 
with Ccbe1/ neonates most likely reflects effects of the spe-
cific genetic backgrounds (C3H and NMRI) that ameliorate 
the effects of dominant-negative VEGFR3 kinase-dead re-
ceptor expression, and permit the survival of Vegfr3kd/+ animals 
that are also highly deficient in lymphatic function (Martel 
et al., 2013).
Failure of lung inflation is not due to surfactant  
deficiency or compressive pleural effusions
Initial inflation of the neonatal lung requires much greater 
force than subsequent inflations, even those occurring only 
minutes later (Milner and Sauders, 1977; Guyton and Hall, 
2000). Thus, a primary obstacle to neonatal lung inflation is the 
mechanical force needed to open the embryonic lung and allow 
the first entry of air into alveoli. The critical known regulator 
of this mechanical force is surfactant, a protein-phospholipid 
mix that increases pulmonary compliance through effects 
on alveolar surface tension and is required for lung inflation 
(Nogee et al., 1994; Clark et al., 1997). E19.5 Ccbe1/ and 
Vegfr3kd/kd lungs contained normal levels of pro-SPC (Fig. 3 C), 
normal amounts of glycogen (a surfactant precursor that accu-
mulates with a block in surfactant production; Bourbon et al., 
1982; Compernolle et al., 2002; Fig. 5, A and B), and normal 
amounts of total lung phospholipid (Fig. 5 C). In addition, 
transmission electron microscopy of E19.5 Ccbe1/ embryo 
lungs revealed a normal number and morphology of both Type I 
and Type II pneumocytes, including the presence of typical 
lamellar bodies, and abundant extracellular, alveolar surfactant 
(Fig. 5, D and E; representative of three Ccbe1/ and litter-
mate control lungs studied). These studies eliminate loss of sur-
factant as the basis for failure of lung inflation in neonates 
lacking lymphatic function.
A second means by which loss of lymphatic function might 
prevent lung inflation is through external compression of the 
lung by pleural effusions that might accumulate in the absence 
of lymphatic drainage. To address this possibility, we histo-
logically examined the intact chests of Vegfr3kd/kd and Ccbe1/ 
neonates. Cyanotic lymphatic-deficient neonates often had 
minimal pleural effusions (e.g., Fig. 5 F and Fig. 2 C), whereas 
(Wilms Tumor 1 [WT1]). Bars, 50 µm. Representative images are shown from 3 control and 3 lymphatic-deficient embryos examined from 3 independent 
litters in each group. Arrows indicate PROX1+ nuclei surrounded by LYVE1+ cell membrane in lymphatic endothelial cells (F). (N) qPCR was used to mea-
sure relative mRNA expression levels of the indicated lung cell marker genes in littermate control and Ccbe1/ neonatal lungs after C-section at E18.5. 
Quantitative data are represented as mean and SEM from 5–7 control and 4–6 Ccbe1/ E18.5 embryos examined from 2 independent litters in each 
group. Asterisk indicates P < 0.05 compared with control.
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Pulmonary lymphatic function is present before birth
Previous studies of lymphatic function around the time of birth 
have used catheter-based flow measurements to demonstrate 
that lymphatic drainage from the lung does not rise signifi-
cantly during or immediately after birth in lambs (Bland et al., 
1982). These studies suggested that lymphatic function might 
be required prenatally, and not merely around the time of birth, 
for neonatal lung inflation. Lymphatic endothelial cells are 
present in the lung as early as E12.5 and lymphatic vessels with 
visible lumens can be seen as early as E14.5 (Kulkarni et al., 
2011), but whether pulmonary lymphatics function before 
birth is not known. To measure lymphatic function in the pre-
natal lung, we injected rhodamine-dextran through the uterine 
and chest walls into the lungs of live Prox1GFP transgenic 
lymphatic-deficient neonates with the largest pleural effu-
sions were frequently not cyanotic due to successful inflation 
of a part of the lung (Fig. 5 F). Thus, lung inflation in neonates 
lacking lymphatic function did not correlate with either the 
presence or size of an associated pleural effusion. To geneti-
cally test the requirement for pleural lymphatic function in 
neonatal respiration, we generated WT1-Cre;Ccbe1flox/flox ani-
mals in which CCBE1 is deleted from the mesothelium that 
forms the pleura. WT1-Cre;Ccbe1flox/flox animals lacked all 
pleural lymphatic vessels (Fig. 5 G) but did not exhibit neo-
natal respiratory failure (Fig. 5 H). These observations suggest 
that failure of lung inflation reflects a lung-intrinsic, mechani-
cal requirement for lymphatic function distinct from that 
of surfactant.
Figure . Neonatal respiratory failure in mice lacking lymphatics results from failure of lung inflation. (A) Exposure of Ccbe1/ and littermate 
control neonates to 100% oxygen (O2) for 30 min. Bars, 5 mm. Images are representative of 4 control and 3 Ccbe1/ neonates from 1 litter. (B and C) Flota-
tion of cyanotic Ccbe1/ and Vegfr3kd/kd neonate lungs in saline compared with control littermates and non-cyanotic Ccbe1/ or Vegfr3kd/kd neonatal 
lungs. Bars, 5 mm. Images are representative of 24 control and 9 lymphatic-deficient neonates examined from 5 independent experiments. (D) H-E–stained 
sections of lung from cyanotic and non-cyanotic neonates. Bars, 200 µm. Representative images are shown from 6 control, 5 cyanotic, and 3 non-
cyanotic Vegfr3kd/kd neonates examined from 4 independent litters in each group.
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littermates at this time point (Fig. 6, B and C). At E17.5 alveoli 
are present, and while some Ccbe1/ and Vegfr3kd/kd lungs 
did not differ markedly from those of control littermates (e.g., 
Fig. 6 D), others displayed thickened septae and smaller alveolar 
area (e.g., Fig. 6 E). By E18.5, the alveoli of all Ccbe1/ and 
Vegfr3kd/kd embryonic lungs appeared smaller than those of con-
trol littermates, the alveolar septae were significantly thicker, 
and the alveolar was significantly reduced (Fig. 6, D–G). Consis-
tent with molecular findings supporting normal growth and 
maturation of lung cell types in Ccbe1/ and Vegfr3kd/kd em-
bryos, the DNA content and dry weights of E18.5 Ccbe1/ 
lungs were similar to those of control littermates (Figs. 6, 
H and I). These findings indicate that lymphatic vessels function 
embryos at E18.5. Selective uptake and passage of rhodamine-
dextran in GFP+ lymphatic vessels was readily detected (Fig. 6 A), 
demonstrating active lymphatic drainage of the late gestation 
mouse lung. Similar studies revealed active lymphatic function 
with luminal rhodamine-dextran in GFP+ lymphatics at E17.5 
(Fig. 6, B and C). To further investigate the impact of prenatal 
pulmonary lymphatic function, we next examined the lungs 
of late gestation Ccbe1/ and Vegfr3kd/kd embryos that were har-
vested after immersion of the gravid uterus in ice-cold saline 
for 45 min, an approach which preserves the late gestation chest 
and lung as they exist in utero before any air inflation. The 
E16.5 mouse lung lacks well-formed alveoli, and Ccbe1/ and 
Vegfr3kd/kd lungs were indistinguishable from those of control 
Figure . Lack of lung inflation in neo-
nates lacking lymphatics is not due to 
surfactant deficiency or the effect of 
large pleural effusions. (A and B) Periodic 
acid-Schiff (PAS) staining for levels of the 
surfactant precursor glycogen in the lungs of 
Ccbe1/, Vegfr3kd/kd, and control littermate 
neonates. Bars, 50 µm. Representative images 
are shown from 5–6 littermate control and  
4–5 lymphatic-deficient neonates per genotype 
examined from 3–4 litters in each group. Ar-
rows indicate glycogen-rich cells in the large 
airways. (C) Phospholipid content of Ccbe1/ 
and littermate control neonatal lungs. Quanti-
tative data are represented as mean and SEM 
from 3 control and 5 Ccbe1/ animals exam-
ined from 2 independent litters (P = 0.93).  
(D) Transmission electron microscopy of the 
lungs of Ccbe1/ neonates reveals surfactant 
(S) in pulmonary alveoli (left), the presence of 
lamellar bodies (LB) in Type II pneumocytes 
(middle), and Type I alveolar pneumocytes 
(right). Bars, 2 µm. Images are representative 
of 3 animals studied for each genotype from 
2 independent litters. (E) Representative im-
ages of active surfactant secretion and abun-
dant alveolar surfactant are shown in 
Ccbe1/ lungs using electron microscopy. 
Bars, 1 µm. (F) H-E–stained sections of  
the intact chest of Vegfr3+/+, non-cyanotic 
Vegfr3kd/kd, and cyanotic Vegfr3kd/kd neonates 
are shown. The schematic on the left indi-
cates the approximate plane of frontal section 
for each set of images. The location of lung  
(L) and pleural effusion (PE) are indicated. Note 
the presence of a very large effusion in this 
non-cyanotic Vegfr3kd/kd neonate compared 
with that of a cyanotic Vegfr3kd/kd littermate. 
Bars, 1,000 µm. (G) LYVE1-PROX1 staining for 
intercostal (top) and lung parenchymal (bot-
tom) lymphatic vessels in WT1-Cre;Ccbe1flox/flox 
and littermate control animals. Arrows indi-
cate PROX1+ nuclei surrounded by LYVE1+ cell 
membrane in lymphatic endothelial cells. Bars, 50 µm. (H) Non-cyanotic WT1-Cre;Ccbe1flox/flox animals after C-section at E19.5. Representative images 
are shown examined from 10 littermate control and 3 WT1-Cre;Ccbe1flox/flox embryos from 2 independent litters (G and H). Bar, 5 mm.
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Figure . The lung lymphatic vascular network is functional during late gestation. (A) Rhodamine-labeled dextran (dextran-TMR) injected into the 
lungs of live E18.5 Prox1GFP transgenic embryos is selectively taken up by GFP+ lymphatic vessels. Bars, 250 µm. (B and C) Rhodamine-labeled dextran (dextran-
TMR) injected into the lungs of live E17.5 Prox1GFP transgenic embryos is detected in the lumen of GFP+ lymphatic vessels (C). Bars, 250 µm. Representative 
images in A–C are shown from 6 embryos from 4 litters. (D and E) H-E staining of Ccbe1/, Vegfr3kd/kd, and littermate control embryonic lungs harvested after 
uterine immersion in ice-cold saline to preserve their in utero state at E16.5, E17.5, and E18.5. Bars, 200 µm. Representative images are shown from 3–7 control 
and 3–7 lymphatic-deficient embryos per time point examined from 2–4 independent litters. (F) Measurement of alveolar septal thickness and alveolar area in 
Ccbe1/ and littermate control lungs at E17.5 and E18.5. Quantitative data represent mean and SEM from 3–7 control and 3–7 Ccbe1/ embryos per time 
point from 2–4 independent litters (P = 0.015 and P = 0.005 for septal thickness and alveolar area at E18.5, respectively). (G) Measurement of alveolar septal 
thickness and alveolar area in Vegfr3kd/kd and littermate control lungs at E17.5 and E18.5. Quantitative data represent mean and SEM from 3 control and  
3 Vegfr3kd/kd embryos per time point examined from 3 independent litters (P = 0.02 and P = 0.05 for septal thickness and alveolar area at E18.5, respectively).  
(H) DNA content in E18.5 Ccbe1/ and littermate control lungs. Quantitative data are represented as mean and SEM from 13 control and 8 Ccbe1/ embryos 
examined from 3 independent litters (P = 0.58). (I) Dry weight of E18.5-19.5 Ccbe1/ and littermate control lungs. Quantitative data are represented as mean 
and SEM examined from 21 control and 7 Ccbe1/ embryos from 5 independent litters (P = 0.29). Asterisks indicate P < 0.05 compared with control.
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before birth, and that changes in lung architecture associated 
with loss of prenatal lymphatic function are not secondary to 
reduced growth or increased matrix production.
Lymphatic function is required to increase  
lung compliance in late gestation
The prenatal lymphangiograms and histological changes ob-
served in lymphatic-deficient lungs suggested that lymphatic 
function might affect lung structure through changes in the 
physical/mechanical characteristics of the developing lung. The 
lung expands late in gestation, an event attributed to active fetal 
breathing movements (Patrick and Challis, 1980; Kobayashi et al., 
2001). We therefore hypothesized that loss of lymphatic function 
may reduce intrinsic lung compliance, resulting in reduced lung 
expansion in utero and failure of lung inflation after birth. To test 
this hypothesis, we measured the total lung compliance of E18.5 
lungs that were harvested from embryos sacrificed by uterine 
immersion in ice-cold saline. Pressure-volume curves revealed a 
significant reduction in the compliance of prenatal Ccbe1/ 
lungs compared with those of prenatal Ccbe1+/+ control litter-
mates (Fig. 7, A–C, n = 4, P < 0.003). A similar reduction in 
prenatal compliance was observed in some but not all E18.5 
Vegfr3kd/kd lungs (Fig. 7, D–F, n = 6, P > 0.05), consistent with the 
greater variability in neonatal cyanosis observed in Vegfr3kd/kd 
animals compared with Ccbe1/ animals (12/13 cyanotic 
Ccbe1/ neonates vs. 8/13 cyanotic Vegfr3kd/kd neonates). 
Collectively, these studies reveal that lymphatic function in-
creases lung compliance before birth, and that this process 
contributes to successful lung inflation after birth.
DISCUSSION
Of the many physiological challenges that face neonatal 
mammals, successful respiration is the most dramatic and one 
that must be met immediately for survival. Successful neo-
natal respiration relies upon a developmental program that 
prepares the lung for air inflation while it forms in a fluid en-
vironment. In addition to the molecular and cellular events 
required to create lung airways and alveoli, a critical part of 
this developmental preparation is the acquisition of mechani-
cal properties that allow the fluid-filled lung to inflate with 
air after birth. The importance of such mechanical prepara-
tion is revealed by the failure of lung inflation and neona-
tal respiration in both mice and humans that lack surfactant 
(Nogee et al., 1994; Clark et al., 1997), a product of alveolar 
Type II cells which increases lung compliance by reducing al-
veolar surface tension.
Our studies identify lymphatic function as a second 
mechanism by which the developing mammalian lung is me-
chanically prepared for inflation at birth. Analysis of late ges-
tation and neonatal lungs from mice lacking lymphatic vessels 
revealed no changes in the molecular or cellular development 
of the lung, but increased W/D ratios indicated the presence 
of pulmonary edema. These findings suggest that interstitial 
pulmonary edema is responsible for the reduced lung compli-
ance before birth, and for the failure of lung inflation at the 
time of birth observed in the absence of lymphatic function. 
Precisely how pulmonary edema reduces compliance is not 
yet clear, but it seems likely that edema changes the intrinsic 
elastic properties of the lung tissue without altering its cellu-
lar or molecular composition. This model is consistent with 
mechanical studies of adult humans and dogs performed more 
than 50 years ago that revealed reduced lung compliance with 
the onset of acute pulmonary edema (Sharp et al., 1958; Haddy 
and Haddy, 1964). The effects of reduced compliance in the 
mature lung were not as drastic as those we observe in the pre-
natal and neonatal lung, but these studies demonstrate that 
edema alters the intrinsic compliance of an otherwise normal 
Figure 7. Lymphatic function is required to increase 
lung compliance in late gestation. (A) Individual pressure-
volume (P-V) curves for 5 Ccbe1+/+ and 4 Ccbe1/ lungs 
examined from 3 independent litters at E18.5 are shown.  
(B) P-V curves from the samples in A are represented as 
mean and SEM. (C) The calculated compliance of Ccbe1/ 
lungs compared with that of wild-type littermates at E18.5. 
Error bars represent mean and SEM from 5 Ccbe1+/+ and  
4 Ccbe1/ lungs examined from 3 independent litters  
(P = 0.003). (D) Individual pressure-volume (P-V) curves for  
5 Vegfr3+/+ and 6 Vegfr3kd/kd lungs examined from 2 inde-
pendent litters at E18.5 are shown. (E) P-V curves from the 
samples in D are represented as mean and SEM. (F) The cal-
culated compliance of Vegfr3kd/kd lungs compared with that 
of wild-type littermates at E18.5. Error bars represent mean 
and SEM from 5 Vegfr3+/+ and 6 Vegfr3kd/kd lungs examined 
from 2 independent litters (P > 0.05). Asterisk indicates  
P < 0.05 compared with control.
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lymphatic function in premature infants may lead to new ap-
proaches to the prevention and management of RDS that 
focus on reducing pulmonary edema.
MATERIALS AND METHODS
Animals. The Ccbe1LacZ-null allele was generated by our laboratory as de-
scribed previously (referred as Ccbe1; Zou et al., 2013) and maintained on a 
129SV:C57BL/6 mixed background. The offspring of heterozygous matings 
was genotyped by allele-specific PCR using 5-TGGGAGTTGAATCCCT-
GATGGTCT-3 forward and 5-AGGCCATACAAGTGTTGGGCATTG-3 
reverse null allele-specific, and 5-CAGAGCAAAGGGACAACAGGTG-3 
forward and 5-TAAACACGGCAGCAGCAACC-3 reverse wild-type allele-
specific primers. The Ccbe1flox allele was generated by our laboratory as de-
scribed previously (Zou et al., 2013). WT1-Cre animals were obtained from 
The Jackson Laboratory (JAX #010911). Mice carrying the kinase-dead Vegfr3 
allele (aka Chy mice; MRC Harwell) were maintained on a NMRI/C3H 
mixed background (Karkkainen et al., 2001). The Vegfr3kd point mutant al-
lele was genotyped using 5-CTGGCTGAGTCCCTAACTCG-3 forward 
and 5-CGGGGTCTTTGTAGATGTCC-3 reverse primers, followed by 
a restriction enzyme digestion with BglII as previously described (Zhang 
et al., 2010). Prox1GFP BAC transgenic mice were obtained from the Mutant 
Mouse Regional Resource Centers (MMRRC). All animal experiments 
were approved by The University of Pennsylvania Institutional Animal Care 
and Use Committee.
Timed matings and handling of late gestation embryos. Overnight 
timed matings were set up using Ccbe1+/ and Vegfr3kd/+ animals. Embryos 
from these crosses were collected at E16.5, E17.5, E18.5, and E19.5. Natu-
rally born embryos were monitored for 1 h before sacrifice and tissue harvest. 
C-sections were performed at E19.5, during which embryos were removed 
from the uterus rapidly, stimulated manually, and monitored for 1 h. After 1 h, 
the lungs were collected for histology or lung dissection for testing flotation 
and wet to dry measurements. To examine prenatal lung morphology and 
development before air exposure and extra-uterine respiratory changes, the 
embryos were sacrificed in utero by immersing the gravid uterus in ice-cold 
PBS for 45 min before harvesting the embryos from the uterus under fluid. 
Prenatal whole chests and lungs were used for histology, transmission electron 
microscopy, phospholipid, DNA content, and compliance measurements.
Histological procedures and immunohistochemistry. Embryos and tissues 
were fixed in 10% formalin overnight, dehydrated in 100% ethanol, and embed-
ded in paraffin. 8-µm-thick sections were used for hematoxylin-eosin, periodic 
acid-Schiff (PAS), trichrome, and immunohistochemistry staining. The following 
primary antibodies were used for immunostaining: anti-LYVE1 (R&D Systems), 
anti-PROX1 (Abcam), anti-PECAM1 (R&D Systems; clone: 693102), anti–
pro-surfactant protein C (pro-SPC; EMD Millipore), anti-Clara cell 10 (CC10; 
Santa Cruz Biotechnology, Inc.), anti-Podoplanin (Abcam), anti–Caveolin-1 
(BD), anti-PDGFR (Cell Signaling Technology), anti-PDGFR (Cell Signal-
ing Technology), anti-SM22 (Abcam), anti-WT1 (Santa Cruz Biotechnology, 
Inc.), anti-Vimentin (Santa Cruz Biotechnology, Inc.), anti-Desmin (Dako), and 
anti-NG2 (EMD Millipore). Detailed histology procedures can be found on the 
University of Pennsylvania Molecular Cardiology Research Center Histology 
and Gene Expression Core website. Microscopic images were taken on a micro-
scope (Eclipse 80i; Nikon) connected to a camera (DS-Ri1; Nikon). Alveolar 
wall thickness (averaging 50–100 measurements per embryo) and alveolar area 
(averaging the total alveolar area in 5–15 vision fields per embryo) were per-
formed in Elements software (Nikon) using a 40× objective.
Gene expression analysis. Quantitative real-time PCR analysis was 
used to measure the expression of late lung developmental markers 
in Ccbe1/ and control embryos at E18.5. Total RNA was isolated 
with RNeasy micro kit (QIAGEN) followed by reverse transcrip-
tion at 42°C for 50 min from 1 µg total RNA using the Superscript II 
Reverse transcription (Invitrogen). Real-time PCR was performed in 
lung. Our findings are also consistent with a previous study 
that reported reduced postnatal survival of mice in which a 
dominant-negative VEGFR3 ectodomain inhibited lymphatic 
growth specifically in the lung (Kulkarni et al., 2011). How-
ever, because these animals retained some lymphatic function 
and were not cyanotic at birth, the prenatal role of lymphatic 
vessels in the lung was not revealed by these studies.
Why do lymphatics play such an important mechanical 
role in the developing and neonatal lung? There are several 
molecular and physiological explanations for this observation. 
The lung develops with abundant airway luminal fluid that is 
required for normal organ growth (Moessinger et al., 1990). 
In late gestation and immediately after birth this fluid is ac-
tively transported from the airway into the interstitium by the 
epithelial sodium channel ENaC in a process that is required 
for neonatal respiration (Hummler et al., 1996). Thus, the late 
gestation and neonatal lung acquires excess interstitial fluid by 
a mechanism of active transport that is not active in the ma-
ture animal. In addition, interstitial fluid is removed from the 
lung through Starling forces in the lung blood vascular capil-
lary network much more efficiently after birth due to large 
increase in pulmonary blood flow that accompanies closure 
of the ductus arteriosus. Finally, initial inflation of the lung re-
quires much greater negative inspiratory pressure than does 
inflation at later time points after birth and in mature animals 
(Milner and Sauders, 1977; Guyton and Hall, 2000). Thus, any 
reduction in compliance due to interstitial edema is likely to 
have a smaller effect in mature animals compared with a neo-
nate attempting to take its first breath. This unique set of mo-
lecular and physiological conditions is likely to explain why 
lymphatic drainage of interstitial fluid in the late gestation lung 
is essential for lung inflation.
An important clinical question raised by these mouse ge-
netic studies is whether and to what extent loss of lymphatic 
function might affect neonatal respiration in human infants. 
Human infants with congenital pulmonary lymphangiecta-
sia (CPL), a rare disorder associated with primary pulmonary 
lymphatic defects, experience cyanosis and death immediately 
after birth that is identical to the phenotype we observe in 
Ccbe1/ and Vegfr3kd/kd neonatal mice (Laurence, 1955; Noonan 
et al., 1970). CPL has also been reported in association with 
Hennekam syndrome (Bellini et al., 2003), a primary human 
lymphatic disorder which may result from loss of CCBE1 (Alders 
et al., 2009), indicating that our findings in mice are likely to 
apply to human neonatal lung inflation.
RDS in premature infants is attributed primarily to a lack 
of surfactant that is not produced until late gestation. Our his-
tological studies do not reveal significant differences between 
control and lymphatic-deficient embryo lungs until E18.5, 
suggesting that, like surfactant, lymphatic function may be 
most active in the period immediately preceding birth. Thus, 
the mechanical role of lymphatics in the developing lung is 
likely to overlap both temporally and functionally with that of 
pulmonary surfactant, and inadequate lymphatic function may 
contribute significantly to the RDS experienced by prema-
ture infants. Future studies that specifically address the role of 
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chest walls into the lungs of live Prox1GFP transgenic embryos at E18.5 and 
E17.5. Selective uptake and passage of rhodamine-dextran in GFP positive 
lymphatic vessels was detected 45 min after the injections. The embryonic 
lungs were removed and imaged under a fluorescent research stereomicroscope 
(SZX16; Olympus) equipped with a camera system (DP72; Olympus).
Compliance measurements. The custom set-up to measure lung compli-
ance consisted of a PBS reservoir attached via flexible tubing to a long glass 
capillary tube that was mounted horizontally. The other end of the capillary 
tube was pulled to form a microneedle. The entire system was flushed with 
PBS to remove any air and a small droplet of vegetable oil was placed in the 
capillary tube as a fiducial marker. Explanted E18.5 Ccbe1/, Vegfr3kd/kd, and 
control lungs were intubated with a microneedle and secured with a modi-
fied finger trap suture. Lung transmural pressure was changed by adjusting the 
reservoir height to alter the lumenal pressure applied to the explants. Lung 
volume change was calculated by measuring the displacement of the oil drop 
in the capillary tube (L) and multiplying by the cross-sectional area of the 
capillary tube (/4*ID2). Several inflation and deflation cycles were performed 
and data were collected at several pressures over a single inflation and deflation 
cycle. Compliance was calculated as the slope of the pressure-volume curve.
Presentation of data and statistical analysis. Macroscopic pictures and 
microscopic images are representative of three or more independent experi-
ments. Microscopic image processing and analysis were performed using 
Photoshop (Adobe) and Fiji software (National Institutes of Health). Results 
are shown as mean and SEM. Statistical analyses were performed using Stu-
dent unpaired two-tailed t test or 2 analysis using Prism 5 software. A differ-
ence was considered statistically significant at P < 0.05.
Online supplemental material. Video 1 shows that Ccbe1/ neonates 
are born alive and exhibit normal respiratory movements. Video 2 shows 
that Vegfr3kd/kd neonates are born alive and exhibit normal respiratory move-
ments. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20132308/DC1.
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